Blast from the Past: Reassessing Forgotten Translation Inhibitors, Antibiotic Selectivity, and Resistance Mechanisms to Aid Drug Development, Molecular Cell, vol.61, issue.1, pp.3-14, 2016. ,
DOI : 10.1016/j.molcel.2015.10.019
A combined cryo-EM and molecular dynamics approach reveals the mechanism of ErmBL-mediated translation arrest, Nature Communications, vol.42, p.12026, 2016. ,
DOI : 10.1016/j.molcel.2015.04.014
Cardiovascular risk reduction: the future of cholesterol lowering drugs, Current Opinion in Pharmacology, vol.27, pp.62-69, 2016. ,
DOI : 10.1016/j.coph.2016.01.007
Structural basis for the inhibition of the eukaryotic ribosome, Nature, vol.135, issue.7519, pp.517-522, 2014. ,
DOI : 10.1038/nature13737
Structural aspects of messenger RNA reading frame maintenance by the ribosome, Nature Structural & Molecular Biology, vol.140, issue.5, pp.555-560, 2010. ,
DOI : 10.1107/S0907444998003254
A Small-Molecule Anti-secretagogue of PCSK9 Targets the 80S Ribosome to Inhibit PCSK9 Protein Translation, Cell Chemical Biology, vol.23, issue.11, pp.1362-1371, 2016. ,
DOI : 10.1016/j.chembiol.2016.08.016
Amicoumacin A induces cancer cell death by targeting the eukaryotic ribosome, Scientific Reports, vol.131, issue.1, p.27720, 2016. ,
DOI : 10.1016/0022-1759(90)90187-Z
Programmed drug-dependent ribosome stalling, Molecular Microbiology, vol.69, issue.4, pp.811-824, 2009. ,
DOI : 10.1111/j.1365-2958.2008.06576.x
Andrew Alspaugh 1,2, * 1 Department of Medicine 2 Department of Molecular Genetics and Microbiology Duke University School of Medicine ,